As the pandemic still rages in many countries and bruised countries like the UK take their first steps to kick start the economy will we return to our normal reliance on the global supply chains? We business and the public look to buy products made closer to home, Buy British? Will the business be able to sustain the higher costs? The fragility of the global supply chain became very apparent as first China then India closed down and the pharma supply chain to most of the world was under threat. Britain has a pandemic and Brexit to deal with in the coming months and many of the companies who wish to supply the UK will be watching closely to see what the MHRA will announce in the coming months. The NHS keeps the costs of medicines in the UK down and therefore this is another consideration for suppliers is there enough margin, is it worth the effort should they focus on bigger markets. Over the past few months, the key UK suppliers have collaborated to ensure the efficient use of resources and to protect the fragile supply chain to maintain the supply of key medicines, sharing intelligence to ensure active substances and excipients were used wisely to prevent out of stock situations. It is unlikely that the UK will run a buy British for pharmaceuticals as the NHS probably cannot afford to.
Buy British, will the public shun Chinese products?
by Jackie (née Heneghan) Peck | Jun 25, 2020 | Blog
Recent Posts
Testimonials
‘Really informative, knowledgeable and interactive. Would recommend.’ Rachel Bown
GDP/RP Training
The course is very informative and comprehensive which covers all aspects of EU GDP guidelines.
Haidar Al-Bukhari
I attended one of the first virtual GDP Responsible Person Cogent “Gold Standard” training sessions due to the Covid-19 social distancing requirements. regardless of the circumstances the training was well organised and delivered to the required standard. This is why I recommended my associates to utilise PCL. Thank you Ryan, Sally, Adel and Jackie. Goncalo Sousa – Quality Head UK at the Janssen Pharmaceutical Companies of Johnson & Johnson 05/05/2020
Cogent Gold Standard GDP Online Training
“For someone with a bare minimal knowledge of WDA this course helped understand the legal, general and business complexities quite well.” Cogent Online Training – March 2021
Cogent - March 2021
“Well prepared and delivered presentations which were insightful, interesting and helpful to any new RP.” – January 2021
Cogent - January 2021
John Finey was excellent & encouraged two-way training e.g. specific experiences the attendees had encountered in their working lives. 18/02/2020
Cogent Gold Standard GDP Online Training
“Excellent training sessions provided. I have thoroughly enjoyed and learned in all sessions. Steven presented and taught the content very well and was very knowledgeable about all topics, and supported further with any adhoc questions through the training. Thank you :)” – Cogent RP Training – April 2024
Excellent Training Sessions
“Very efficient and effective. Covered all areas of training.” – John Elliott KWE
GDP/RP Training
“Really well presented and explained. Have a much better understanding of a very involved subject.” Vicky Stones 10/10
Export Training
“Steve is a fantastic trainer with a wealth of knowledge and the ability to be able to apply that knowledge to real life situations. Fantastic course extremely well delivered. Thank you.” – MM, Kuehne+Nagel – Cogent RP Training – April 2024
Fantastic course extremely well delivered